Organovo Holdings has announced a partnership with Autodesk to create the first 3D design software for bioprinting.

A number of projects are starting to work on 3D printing human tissues and body parts, such as a team at the Wake Forest Institute for Regenerative Medicine, who are exploring ways to 3D print a kidney. Organovo Holdings, a manufacturer of functional 3D human tissues for medical research and therapeutic applications, is partnering with researchers at Autodesk, the leader in cloud-based design and engineering software, to create the first 3D design software for bioprinting.

The software will be used to control Organovo's NovoGen MMX bioprinter, and will be a big step forward in usability and functionality for designing 3D human tissues. It also has the potential to open up bioprinting to a wider group of users. Keith Murphy, chairman and CEO of Organovo, said:

$15 provides access to this article and every case-study, interview, and analysis piece that we publish for the next 30 days. Our Premium Subscription also provides access to a database of over 100,000 articles on innovation in brand, customer, and retail experience.
Already a subscriber? Log in